These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16179803)

  • 1. Effect of inhibition of farnesylation and geranylgeranylation on renal fibrogenesis in vitro.
    Masterson R; Kelynack K; Hewitson T; Becker G
    Nephron Exp Nephrol; 2006; 102(1):e19-29. PubMed ID: 16179803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines.
    Lerner EC; Zhang TT; Knowles DB; Qian Y; Hamilton AD; Sebti SM
    Oncogene; 1997 Sep; 15(11):1283-8. PubMed ID: 9315095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Ras and related guanosine triphosphate-dependent proteins as a therapeutic strategy for blocking malignant glioma growth: II--preclinical studies in a nude mouse model.
    Pollack IF; Bredel M; Erff M; Hamilton AD; Sebti SM
    Neurosurgery; 1999 Nov; 45(5):1208-14; discussion 1214-5. PubMed ID: 10549939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of geranylgeranylated proteins in human mesangial cell proliferation.
    Khwaja A; Sharpe CC; Noor M; Hendry BM
    Kidney Int; 2006 Oct; 70(7):1296-304. PubMed ID: 16929252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of protein geranylgeranylation causes a superinduction of nitric-oxide synthase-2 by interleukin-1beta in vascular smooth muscle cells.
    Finder JD; Litz JL; Blaskovich MA; McGuire TF; Qian Y; Hamilton AD; Davies P; Sebti SM
    J Biol Chem; 1997 May; 272(21):13484-8. PubMed ID: 9153192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
    Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
    Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting geranylgeranylation blocks growth and promotes apoptosis in pulmonary vascular smooth muscle cells.
    Stark WW; Blaskovich MA; Johnson BA; Qian Y; Vasudevan A; Pitt B; Hamilton AD; Sebti SM; Davies P
    Am J Physiol; 1998 Jul; 275(1):L55-63. PubMed ID: 9688935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells.
    Morgan MA; Sebil T; Aydilek E; Peest D; Ganser A; Reuter CW
    Br J Haematol; 2005 Sep; 130(6):912-25. PubMed ID: 16156861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of type I collagen gene expression in normal and systemic sclerosis fibroblasts by a specific inhibitor of geranylgeranyl transferase I.
    Rosenbloom J; Saitta B; Gaidarova S; Sandorfi N; Rosenbloom JC; Abrams WR; Hamilton AD; Sebti SM; Kucich U; Jimenez SA
    Arthritis Rheum; 2000 Jul; 43(7):1624-32. PubMed ID: 10902768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro.
    Masterson R; Hewitson TD; Kelynack K; Martic M; Parry L; Bathgate R; Darby I; Becker G
    Nephrol Dial Transplant; 2004 Mar; 19(3):544-52. PubMed ID: 14767007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of the novel farnesyltransferase inhibitor RPR130401 and the geranylgeranyltransferase-1 inhibitor GGTI-298 disrupts MAP kinase activation and G(1)-S transition in Ki-Ras-overexpressing transformed adrenocortical cells.
    Mazet JL; Padieu M; Osman H; Maume G; Mailliet P; Dereu N; Hamilton AD; Lavelle F; Sebti SM; Maume BF
    FEBS Lett; 1999 Oct; 460(2):235-40. PubMed ID: 10544242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts.
    Sun J; Qian Y; Hamilton AD; Sebti SM
    Oncogene; 1998 Mar; 16(11):1467-73. PubMed ID: 9525745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
    Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
    Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis.
    Yokoi H; Sugawara A; Mukoyama M; Mori K; Makino H; Suganami T; Nagae T; Yahata K; Fujinaga Y; Tanaka I; Nakao K
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S134-8. PubMed ID: 11576939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of cancer cell invasion by a geranylgeranyltransferase-I inhibitor.
    Kusama T; Mukai M; Tatsuta M; Matsumoto Y; Nakamura H; Inoue M
    Clin Exp Metastasis; 2003; 20(6):561-7. PubMed ID: 14598891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of GGTase-I and FTase disrupts cytoskeletal organization of human PC-3 prostate cancer cells.
    Virtanen SS; Sandholm J; Yegutkin G; Kalervo Väänänen H; Härkönen PL
    Cell Biol Int; 2010 Aug; 34(8):815-26. PubMed ID: 20446922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farnesylated RhoB prevents cell cycle arrest and actin cytoskeleton disruption caused by the geranylgeranyltransferase I inhibitor GGTI-298.
    Allal C; Pradines A; Hamilton AD; Sebti SM; Favre G
    Cell Cycle; 2002; 1(6):430-7. PubMed ID: 12548020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of RhoA and RalB in geranylgeranyltransferase I inhibitor-mediated inhibition of proliferation and migration of human oral squamous cell carcinoma cells.
    Hamada M; Miki T; Iwai S; Shimizu H; Yura Y
    Cancer Chemother Pharmacol; 2011 Sep; 68(3):559-69. PubMed ID: 21107573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Ras and related G-proteins as a therapeutic strategy for blocking malignant glioma growth.
    Bredel M; Pollack IF; Freund JM; Hamilton AD; Sebti SM
    Neurosurgery; 1998 Jul; 43(1):124-31; discussion 131-2. PubMed ID: 9657198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyltransferase I inhibitor.
    Lerner EC; Qian Y; Hamilton AD; Sebti SM
    J Biol Chem; 1995 Nov; 270(45):26770-3. PubMed ID: 7592913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.